Neupro® (rotigotine transdermal system): First FDA-Approved Parkinson's Disease Patch
Filed in archive Treatment on May 10, 2007
The first patch for Parkinson's disease has recently been approved by the USFDA: Neupro® (rotigotine transdermal system).
A product of Schwarz Bioscience (U.S. subsidiary of Schwarz Pharma AG), Neupro works by delivering the drug rotigotine (a dopamine agonist) continuously through the skin (transdermal) using a silicone-based patch that is replaced every 24 hours.
[A dopamine agonist works by activating dopamine receptors in the body, mimicking the effect of the neurotransmitter dopamine.]
Neupro is the first transdermal patch approved for the treatment of symptoms of Parkinson's disease - belongs to a group of conditions called motor system disorders that is a result of the loss of dopamine-producing brain cells.
Read the full report from Schwarz Pharma and FDA.

Tags: Parkinsons disease patch
Vote for Neupro® (rotigotine transdermal system): First FDA-Approved Parkinson's Disease Patch:
|
Rating: 6.00 out of 2 vote(s) cast.
|
Response from:
declan
(12/18/07 6:53pm)
Since starting the patch six weeks ago I have had high blood pressure for the firstime and had almost constant nose bleeds and evntually hospitalised It may not be the patch but I wonder
Response from:
tavel
(01/14/08 12:37am)
has anybody experience wit 12-14 mg daily + ledopad (cienemet )
Response from:
Johnson Chen
(01/16/08 2:51pm)
HealthLat is inviting patients who take Neupro, and physicians who prescribe it to report their experiences with the new drug. Your experiences will help patients needed and make money for you.
You are also welcome to check how Neupro has been used by other patients. It is free.
For details, please visit: http://www.healthlat.com
You are also welcome to check how Neupro has been used by other patients. It is free.
For details, please visit: http://www.healthlat.com
Response from:
Trusted.MD Network
With no cure and still of unknown cause - Crohn's disease - is a chronic, inflammatory bowel disease that affects more than 1 million men and women worldwide.
Most Popular
Allergies
Alzheimer's Disease
Arthritis
Bacteria and Bacterial Infections
Best of
Blog Carnivals
Bone Health
Cancer
Cardiovascular Health
Cases
CFS
Consumer Alert
Controversies
Dental Health
Diabetes
Diagnostics
Diarrhea
Did you know
Diet
Dietary Supplements and Vitamins
